Mammal prolactin variants

Details for Australian Patent Application No. 2003215539 (hide)

Owner Institut National de la Sante et de la Recherche Medicale - Inserm

Inventors Bernichtein, Sophie; Goffin, Vincent; Kelly, Paul A

Agent Griffith Hack

Pub. Number AU-B-2003215539

PCT Number PCT/EP03/00448

PCT Pub. Number WO2003/057729

Priority 02290030.2 08.01.02 EP

Filing date 8 January 2003

Wipo publication date 24 July 2003

Acceptance publication date 26 March 2009

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 02290030.2 08.01.02 EP

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2003215539

26 March 2009 Application Accepted

  Published as AU-B-2003215539

23 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215540-NALLYLOXYETHYL1,2,3,4,5,6-HEXAHYDRO-2,6-METHAN O-3-BENZAZOCINES AND THE USE OF THE SAME AS PHARMACEUTICALS

2003215538-Closed capsule with opening mean